|
|
Article: Acambis to Present Clinical Trial Results on its Investigational West Nile Virus Vaccine at the NFID's 8th Annual Conference on Vaccine Research.
- Article from:
- PR Newswire
- Article date:
- May 11, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
No Vaccine Currently Exists Against the West Nile Virus, Which Caused More Than 2,400 Infections and 88 Deaths Last Year in the US
Acambis' West Nile Vaccine Candidate to Enter the Next Stage of Development Later This Year
CAMBRIDGE, England and CAMBRIDGE, Massachusetts, May 11 /PRNewswire-FirstCall/ -- Acambis plc (Acambis) , a leading developer of vaccines against infectious diseases, announces that Thomas Monath, MD, Chief Scientific Officer of Acambis, will present the results of a Phase I clinical trial of the Company's West Nile virus vaccine candidate, ChimeriVax-West Nile, at the National Foundation for Infectious Disease's (NFID) 8th Annual ...